Thursday, December 12
8:00 – 9:00 AM
John T. Bentivoglio, Partner, Skadden, Arps, Slate, Meagher & Flom LLP
William Gould, Partner, Holland & Knight LLP
8:30 – 9:10 AM
Registration and Continental Breakfast
9:10 – 9:15 AM
FDLI Welcome and Remarks
Laura Brown, Director, Educational Programs, Food and Drug Law Institute
9:15 – 9:45 AM
Keynote Address
Stacy Cline Amin, Chief Counsel, FDA
9:45 – 10:45 AM
Hannah R. Bornstein, Partner, Nixon Peabody LLP
Lauren Misztal, Associate General Counsel, Legal Investigations, Mallinckrodt Pharmaceuticals
Jonathan M. Phillips, Partner, Gibson, Dunn & Crutcher LLP
Moderated by Michael Paddock, Partner, Sheppard Mullin Richter & Hampton LLP
10:45 – 11:00 AM
Coffee and Networking Break
11:00 – 11:55 AM
Concurrent Breakout Sessions:
Lisa M. Dwyer, Partner, King & Spalding LLP
Charles N. Jolly, Of Counsel, Baker Donelson
Moderated by John Claud, Assistant Director, Consumer Protection Branch, US Department of Justice
Frederick (Rick) Ball, Partner, Duane Morris LLP and Treasurer, FDLI Board of Directors
Richard Cleland, Assistant Director, Bureau of Consumer Protection, Division of Advertising Practices, FTC
Aaron Negangard, Chief Deputy Attorney General, Indiana
Moderated by Libby Baney, Partner, Faegre Baker Daniels LLP
Benneville (Ben) Haas, Partner, Latham & Watkins LLP
Eric Heyer, Partner, Thompson Hine LLP
11:55 AM – 12:00 PM
Transition
12:00 – 1:00 PM
Concurrent Breakout Sessions:
Charles Biro, Trial Attorney, Consumer Protection Branch, US Department of Justice
Daniel Jarcho, Partner, Alston & Bird LLP
Moderated by James N. Czaban, Partner, DLA Piper LLP
Desmond Brown, Division of Food Defense Targeting, ORA, FDA
Ted Poplawski, Special Assistant, Division of Import Operations, ORA, FDA
Angel Suarez, Independent Consultant, EAS Consulting Group LLC
Moderated by Robert Durkin, Of Counsel, Arnall Golden Gregory LLP
Perham Gorji, Deputy Chief Counsel for Litigation, Office of the Commissioner, FDA
Katie Laney, Principal Consultant, Validant
Melissa Mendoza, Deputy Director, Office of Compliance and Biologics Quality, Center for Biologics Evaluation and Research, FDA
Moderated by Kalah Auchincloss, Senior Vice President, Regulatory Compliance & Deputy General Counsel, Greenleaf Health, Inc.
1:00 – 2:15 PM
Luncheon Address: Seventh Annual Eric M. Blumberg Memorial Lecture
Richard M. Cooper, Senior Counsel, Williams & Connolly
2:15 PM
Conference Adjournment